Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth
Xiaonan Guo,1,* Xiaoshuang Zhu,1,* Dakan Liu,1 Yubin Gong,1 Jing Sun,2 Changxian Dong1 1Department of Hemangioma and Vascular Malformation, Henan Provincial People’s Hospital, Zhengzhou, People’s Republic of China; 2Department of Pharmacy, Second Military Medical University, Sha...
Saved in:
Main Authors: | Guo XN, Zhu XS, Liu DK, Gong YB, Sun J, Dong CX |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/74f2fe4a38a149468b5fdba50f39cadc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemangioma subglótico tratado con propranolol: Una nueva alternativa terapéutica. Caso clínico
by: OSORIO M,JAIME, et al.
Published: (2013) -
Propranolol en el Tratamiento de los Hemangiomas de la Infancia
by: KRÄMER H,DANIELA, et al.
Published: (2010) -
Development and characterization of a nanoemulsion containing propranolol for topical delivery
by: Zanela da Silva Marques T, et al.
Published: (2018) -
Combined oral propranolol with intralesional injection of triamcinolone acetonide in treatment of infantile periocular hemangiomas
by: Alsmman AH, et al.
Published: (2017) -
Relationship between serum miR-199a-5p and miR-378a-3p levels and recurrence of infants with proliferative facial hemangioma after propranolol withdrawal
by: GUO Yan, et al.
Published: (2022)